Richard Thomas Marconi

Midlothian, VA, United States of America

Richard Thomas Marconi

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Midlothian, VA (US) (2010 - 2022)
  • Richmond, VA (US) (2017 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Richard Thomas Marconi: A Pioneer in Vaccine Innovation**

Introduction

Richard Thomas Marconi, an innovative inventor based in Midlothian, VA, has made a significant impact in the field of vaccine development with a total of 13 patents to his name. His work focuses on combating infectious diseases through cutting-edge technologies that enhance vaccine efficacy and diagnostic capabilities.

Latest Patents

Among his latest patents, Marconi has developed chimeric vaccine antigens for anaplasmosis. This invention includes chimeric recombinant polypeptides, known as chimeritopes, designed for vaccines against Anaplasmosis. These chimeritopes consist of antigenic segments from three proteins (OmpA, AipA, and Asp14) combined with a non-antigenic segment of an Osp protein (e.g., OspC) that features specific structural characteristics. Additionally, he has introduced chimeric recombinant proteins for the detection and diagnosis of Lyme disease, along with methods and devices to perform immunoassays leveraging these proteins.

Career Highlights

Marconi's illustrious career includes significant tenures at prestigious organizations. He has contributed his expertise at Virginia Commonwealth University, where he engaged in advanced research projects. He also played a crucial role at Zoetis Services LLC, a leading animal health company, where his focus on vaccine development further solidified his reputation in the field.

Collaborations

Throughout his career, Marconi has collaborated with notable professionals, including Christopher G. Earnhart and Jason A. Carlyon. These partnerships have facilitated the exchange of ideas and driven innovative solutions in the sphere of vaccine research and development.

Conclusion

Richard Thomas Marconi stands out as a distinguished inventor whose contributions to vaccine technology continue to shape the future of infectious disease management. With a robust portfolio of patents and a commitment to collaborative research, he embodies the spirit of innovation in the scientific community. His work not only advances scientific knowledge but also has the potential to make a lasting impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…